comprehensive -WSS

comprehensive

author：explore 2025-10-01 04:13:07 - browse：583

Bristol Myers Squibb sign — Courtesy Bristol Myers Squibb

Bristol Myers Squibb said that it would purchase Mirati Therapeutics, maker of the cancer drug Krazati, for $4.8 billion in cash in a deal that shows the continued interest of large pharmaceutical firms in relatively small “bolt-on” acquisitions.

Bristol said that it would pay $58.00 per share for Mirati, and would hold another $12.00 per share, or a total of $1 billion, to be paid if one of two different applications for an additional use for Krazati is approved within seven years after the merger closes.

Chris Boerner, Bristol’s chief operating officer and CEO-elect, said in a statement that Mirati had several cancer drugs in development that could deliver sales in the latter half of the decade and beyond, when investors worry that Bristol will need new products to sustain its growth.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Bird flu: Don't repeat Covid's 'health versus the economy' framing

focus

WSS

Wearables generate powerful data but its not useful to doctors, yet

Trump allegedly attempted to have surveillance video deleted: Special Counsel

'The boss' wants server deleted: New allegations emerge in Trump indictment

‘We were in the air.’ Mississippi family recounts surviving tornado that tore mobile home apart

Alexander Hamilton and the argument for universal insurance

Case highlights the risks of experimental stem cell therapy

focus

comprehensive

hotspot

In Memoriam: Notable people who died in 2023

An outrageous hospital charge: I paid $710 for an hour of babysitting

Anesthesiologist group: stop taking Ozempic before surgery

Marc Tessier

As demand for Covid shots wanes, Moderna seeks its next success

Readout LOUD podcast: Live from STAT Breakthrough Summit West

The high cost of giving birth even with insurance

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

At least 13 dead in Texas as scorching temps continue

CDC: Cases of alpha

Wikipedia

Cytokinetics CEO stresses company can launch heart drug on its own

Arc Institute generative AI designs new CRISPR systems

Alexander Hamilton and the argument for universal insurance

Trump allegedly attempted to have surveillance video deleted: Special Counsel

Stoke drug shows lower activity against childhood epilepsy

An outrageous hospital charge: I paid $710 for an hour of babysitting

Wikipedia

focus

entertainment

explore